Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $115,584 - $214,835
-914 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $64,132 - $104,656
284 Added 45.08%
914 $232,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $83,656 - $182,645
-377 Reduced 37.44%
630 $242,000
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $130,819 - $236,624
1,007 New
1,007 $237,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fortis Capital Management LLC Portfolio

Follow Fortis Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Capital Management LLC with notifications on news.